Polycythemia vera secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2] Shyam Patel [3] Synonyms and keywords: Polycythemia rubra vera (PRV); Erythremia; Primary polycythemia; Osler-Vaquez disease; splenomegalic polycythemia

Overview

Secondary prevention strategy following polycythemia vera include low dose aspirin.

Secondary Prevention

Secondary prevention strategy following polycythemia vera include low-dose aspirin 81mg daily to decrease the risk of the following complications:^[1]

Cardiovascular death
Non-fatal myocardial infarction
Non-fatal stroke

References

↑ Maeda T, Wakasawa T, Shima Y, Tsuboi I, Aizawa S, Tamai I (2006). “Role of polyamines derived from arginine in differentiation and proliferation of human blood cells”. Biol Pharm Bull. 29 (2): 234–9. PMID 16462024.

Template:Hematology

Template:WikiDoc Sources

[pmid16462024-1] Maeda T, Wakasawa T, Shima Y, Tsuboi I, Aizawa S, Tamai I (2006). “Role of polyamines derived from arginine in differentiation and proliferation of human blood cells”. Biol Pharm Bull. 29 (2): 234–9. PMID 16462024.

[1]